Last quarter (Q0 0), Biostar Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q0, Biostar Pharmaceuticals's net income was $-125.19K. See Biostar Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 16	Dec 15	Dec 14	Dec 13	Dec 12
Total Revenue	$ 317.79K	$ 2.38M	$ 27.13M	$ 61.42M	$ 52.73M	$ 49.32M
Cost of Revenue	$ 354.54K	$ 1.47M	$ 16.03M	$ 31.14M	$ 27.05M	$ 19.47M
Gross Profit	$ -36.75K	$ 915.17K	$ 11.10M	$ 30.28M	$ 25.68M	$ 29.85M
Operating Expense	$ -2.88M	$ 4.48M	$ 21.98M	$ 28.97M	$ 24.60M	$ 41.99M
Operating Income	$ 2.84M	$ -3.56M	$ -10.87M	$ 1.31M	$ 1.08M	$ -12.14M
Net Non Operating Interest Income Expense	$ -198.82K	$ -205.03K	$ -274.70K	$ 1.18M	$ 977.07K	$ 211.76K
Other Income Expense	$ 947.39K	$ 723.96K	$ -12.65M	$ -946.21K	$ 600.64K	$ -9.64M
Pretax Income	$ 3.59M	$ -3.05M	$ -23.79M	$ 1.53M	$ 2.66M	$ -21.57M
Tax Provision	$ 2.65M	$ 2.65M	$ 1.32M	$ -3.31M	$ 1.85M	$ -1.58M
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ 934.35K	$ -5.70M	$ -25.11M	$ 4.85M	$ 809.05K	$ -20.00M
Basic EPS	$ 0.68	$ -2.50	$ -11.40	$ 2.31	$ 0.42	$ -14.63
Diluted EPS	$ 0.68	$ -2.50	$ -11.40	$ 2.31	$ 0.42	$ -14.63
Basic Average Shares	$ 10.47M	$ 2.30M	$ 2.21M	$ 2.07M	$ 1.93M	$ 1.37M
Diluted Average Shares	$ 10.47M	$ 2.30M	$ 2.21M	$ 2.07M	$ 1.93M	$ 1.37M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ -2.52M	$ 5.95M	$ 38.00M	$ 60.11M	$ 51.65M	$ 61.46M
Net Income From Continuing And Discontinued Operation	$ 934.35K	$ -5.70M	$ -25.11M	$ 4.85M	$ 809.05K	$ -20.00M
Normalized Income	$ 509.57K	$ -5.87M	$ -13.25M	$ 5.56M	$ 360.28K	$ -12.76M
Interest Expense	$ 201.31K	$ 206.19K	$ 283.60K	$ 154.55K	$ 367.49K	$ 84.39K
EBIT	$ 3.79M	$ -2.84M	$ -23.51M	$ 1.69M	$ 3.02M	$ -21.49M
EBITDA	$ 4.90M	$ -1.70M	$ -21.19M	$ 4.78M	$ 5.81M	$ -19.66M

Currency in USD

Biostar Pharmaceuticals Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing